A Multicentre, Phase 1B/2 Study of Varlitinib in Combination With Gemcitabine and Cisplatin for Treatment naïve Advanced or Metastatic Biliary Tract Cancer.

Trial Profile

A Multicentre, Phase 1B/2 Study of Varlitinib in Combination With Gemcitabine and Cisplatin for Treatment naïve Advanced or Metastatic Biliary Tract Cancer.

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 16 Dec 2016

At a glance

  • Drugs Cisplatin (Primary) ; Gemcitabine (Primary) ; Varlitinib (Primary)
  • Indications Biliary cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors ASLAN Pharmaceuticals
  • Most Recent Events

    • 16 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top